Estimaciones de analistas de Wall Street para Anavex Life Sciences Corp. (AVXL): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-24 | $-0.11 | ||
| 2026-08-28 | $-0.03 | $-0.08 | +62.5% |
| 2026-08-25 | $0.08 | $-0.08 | +200.0% |
| 2026-02-09 | $-0.06 | $-0.10 | +40.0% |
| 2025-11-25 | $-0.11 | $-0.13 | +15.4% |
| 2025-08-12 | $-0.16 | $-0.13 | -23.1% |
| 2025-05-13 | $-0.13 | $-0.16 | +18.8% |
| 2025-02-12 | $-0.14 | $-0.17 | +17.6% |
Ratios de valoración
| Precio / Valor contable | 1.92 |
| EV / EBITDA | -5.71 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $7.3M | $10.7M | $13.3M | $22.3M | $25.2M | $33.0M | $37.9M | $43.7M | $41.8M | $37.6M |
| Generales y Administrativos | $8.3M | $5.0M | $6.0M | $6.8M | $5.9M | $9.0M | $13.1M | $12.0M | $11.0M | $13.8M |
| Gastos Operativos | $14.9M | $15.5M | $19.2M | $28.8M | $31.1M | $42.0M | $51.0M | $55.8M | $52.9M | $51.4M |
| Beneficio Operativo | 0 | 0 | 0 | 0 | -$31.1M | -$42.0M | -$51.0M | -$55.8M | -$52.9M | -$51.4M |
| EBITDA | -$15.0M | -$15.6M | -$19.1M | -$28.9M | -$31.1M | -$37.6M | -$47.6M | -$46.5M | -$43.0M | -$46.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $964000 | 0 | 0 |
| Beneficio Antes de Impuestos | -$14.7M | -$13.4M | -$17.4M | -$26.2M | -$30.6M | -$37.6M | -$47.6M | -$47.5M | -$43.0M | -$46.4M |
| Impuestos | $29615 | $59607 | $72746 | $82181 | -$4.4M | $268000 | $358000 | 0 | 0 | 0 |
| Beneficio Neto | -$14.7M | -$13.5M | -$17.5M | -$26.3M | -$26.3M | -$37.9M | -$48.0M | -$47.5M | -$43.0M | -$46.4M |
| BPA | $-0.42 | $-0.33 | $-0.39 | $-0.54 | $-0.45 | $-0.54 | $-0.62 | $-0.60 | $-0.52 | $-0.54 |
| BPA Diluido | $-0.42 | $-0.33 | $-0.39 | $-0.54 | $-0.45 | $-0.54 | $-0.62 | $-0.60 | $-0.52 | $-0.54 |
| Acciones en Circulación (Diluidas) | $35.2M | $40.8M | $44.7M | $48.9M | $58.2M | $69.8M | $76.9M | $79.8M | $83.5M | $85.3M |
Precio
| Precio | $2.36 |
| Capitalización | $219M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABSI · ARVN · ATXS · CTMX · ERAS · MBX · MGTX
Explorar sector: Healthcare · Biotechnology
Más secciones de AVXL: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones